Article

Free webinars for patients and survivors

Author(s):

Fight Colorectal Cancer is hosting two free webinars for cancer patients, survivors, caregivers and advocates. Fight Colorectal Cancer, formerly the Colorectal Cancer Coalition, is a nonprofit organization dedicated to supporting and educating people with colorectal cancer. Members advocate on behalf of patients and caregivers to increase research funding and influence policy and legislative change. CURE's fall issue will feature an article on people who have made cancer their mission. If you are interested in doing the same, the webinar "Couch Potato Advocacy: 3 Things You Can Do at Home to Help the Fight" will steer you in that direction. It features David Pugach, the American Cancer Society Cancer Action Network's associate director of federal relations, providing "tips on how to take your experience as a cancer fighter and use it to make a difference for all those in the fight of their lives." This webinar is on August 17, 2011, from 8:00 PM to 9:30 PM EDT. To register, click here. Getting cancer is tough enough without having to deal with losing a job or insurance. Learn what your rights are at "Cancer and the Law" hosted by Laura Riley of the Cancer Legal Resource Center (CLRC). Riley will discuss common cancer-related legal issues for patients and survivors, such as employment rights, health insurance options, disability insurance and taking off work for medical reasons. The CLRC is a nonprofit that provides free legal assistance and counseling to cancer patients, survivors, friends and family. This webinar takes place on September 21, 2011, from 8:00 PM to 9:30 PM EDT. To register, click here. And for more information on Fight Colorectal Cancer, you can access their website at fightcolorectalcancer.org.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of women with text.
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Related Content